Eikon Therapeutics, Inc. (EIKN)

NASDAQ: EIKN · Real-Time Price · USD

10.23

+0.50 (5.14%)

At close: Aug 11, 2026, 4:00 PM EDT

10.23

0.00 (0.00%)

After-hours: Aug 11, 2026, 4:10 PM EDT

Eikon Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Income	-338.95	-338.95	-260.34	-265.74
Net Income	-333.64	-333.64	-243.81	-242
Earnings Per Share	-115.29	-115.29	-96.76	-119.40
EPS Growth	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	512.18	335.98	220.11	430.41
Total Debt	254.83	257.32	202.46	31.74
Net Cash (Debt)	257.35	78.66	17.65	398.68
Net Cash Growth	1357.91%	345.59%	-95.57%	-
Net Cash Per Share	4.75	27.18	7.01	196.70

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-188.52	-188.52	-134.8	-190.85
Capital Expenditures	-46.74	-46.74	-84.8	-28.51
Free Cash Flow	-235.26	-235.26	-219.6	-219.36
Free Cash Flow Growth	-	-	-	-